Antonio Olivieri

Global Medical Affairs Executive

Professional Overview
Antonio Olivieri is a seasoned global medical affairs executive with extensive experience in the pharmaceutical and biotechnology industries. He currently serves as the Senior Vice President, Chief Medical Officer, and Head of Global Medical Affairs at Idorsia Pharmaceuticals Ltd., where he oversees the company's worldwide medical strategy and execution.

Experience Summary

Current Role
As the SVP, CMO, and Head of Global Medical Affairs at Idorsia Pharmaceuticals, Antonio is responsible for shaping the medical vision and leading the global medical affairs function. He is instrumental in ensuring the successful development and launch of the company's innovative pharmaceutical products, with a focus on optimizing patient outcomes and advancing medical knowledge.

Career Progression
Prior to joining Idorsia, Antonio held senior medical affairs roles at Alexion Pharmaceuticals, Inc., where he served as the VP of Head of International and Japan Medical Affairs and the VP of Medical Affairs EMEA. He also has extensive experience in the vaccines industry, having worked at GSK Vaccines as the Director of Global Medical Affairs Leader and in various leadership positions within the Vaccine Development and Project Management teams.

Academic Background
Antonio holds a strong academic background, with a focus on medical and pharmaceutical sciences. His education includes relevant specializations that have equipped him with the necessary technical expertise to excel in his field.

Areas of Expertise
Antonio's areas of expertise span across global medical affairs, strategic planning, medical communication, clinical development, and medical team leadership. He has a proven track record of driving innovative medical strategies, fostering collaborative partnerships, and delivering impactful medical and scientific contributions to the industry.

Professional Impact
Throughout his career, Antonio has made significant contributions to the pharmaceutical and biotechnology sectors. He has led the implementation of cutting-edge medical affairs initiatives, spearheaded the development of groundbreaking medical strategies, and actively engaged with key opinion leaders and regulatory bodies to advance the understanding and adoption of novel therapies.

Conclusion
With his extensive experience, deep industry knowledge, and proven leadership skills, Antonio Olivieri is a highly respected global medical affairs executive. In his current role at Idorsia Pharmaceuticals, he is poised to continue driving the company's medical innovation, strengthening its clinical and commercial success, and making a lasting impact on the lives of patients worldwide.